Operating Income - Portage Biotech Inc (NASDAQ:PRTG) - Alpha Spread

Portage Biotech Inc
NASDAQ:PRTG

Watchlist Manager
Portage Biotech Inc Logo
Portage Biotech Inc
NASDAQ:PRTG
Watchlist
Price: 10.21 USD 3.03% Market Closed
Market Cap: 214.4m USD
Have any thoughts about
Portage Biotech Inc?
Write Note

Portage Biotech Inc
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Portage Biotech Inc
Operating Income Peer Comparison

Comparables:
TH
RPTX
AUPH
COV
EDT

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Portage Biotech Inc
NASDAQ:PRTG
Operating Income
-$98.8m
CAGR 3-Years
-88%
CAGR 5-Years
-87%
CAGR 10-Years
-39%
Theratechnologies Inc
TSX:TH
Operating Income
$3.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Repare Therapeutics Inc
NASDAQ:RPTX
Operating Income
-$116.2m
CAGR 3-Years
-30%
CAGR 5-Years
-55%
CAGR 10-Years
N/A
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Operating Income
-$52.9m
CAGR 3-Years
29%
CAGR 5-Years
3%
CAGR 10-Years
-17%
Covalon Technologies Ltd
XTSX:COV
Operating Income
-CA$1.4m
CAGR 3-Years
48%
CAGR 5-Years
23%
CAGR 10-Years
N/A
Spectral Medical Inc
TSX:EDT
Operating Income
-CA$13.7m
CAGR 3-Years
-23%
CAGR 5-Years
-46%
CAGR 10-Years
-1%

See Also

What is Portage Biotech Inc's Operating Income?
Operating Income
-98.8m USD

Based on the financial report for Jun 30, 2024, Portage Biotech Inc's Operating Income amounts to -98.8m USD.

What is Portage Biotech Inc's Operating Income growth rate?
Operating Income CAGR 10Y
-39%

Over the last year, the Operating Income growth was 22%. The average annual Operating Income growth rates for Portage Biotech Inc have been -88% over the past three years , -87% over the past five years , and -39% over the past ten years .

Back to Top